Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
XiTrump Tariff Cut Agreement Signals New Phase in USChina Trade Relations Bessent Anticipates Substantial Disinflation Ahead as Warsh Assumes Fed Leadership Trump Drops IRS Lawsuit in Exchange for 1776 Billion Government Targeting Fund Workforce Pressures Reshape Food Grocery Manufacturing Sector Oxford Economics Report Shows Berkshire Hathaway Revamps Portfolio New Stakes in Delta and Alphabet Signal Shift RBI Tightens Risk Disclosure Norms for Banks Enhanced Granularity Required GAMCO GNT Stock Analysis RangeBound Near 796 20260518 Oakland Home Values Plunge Over 11 in Past Year Among Steepest National Declines Zillow Stocks Gain as Oil Prices and Bond Yields Fall in Broad Market Shift Stellantis to Produce Dongfengs Voyah Electric Vehicles at French Plant Under Joint Venture Valero VLO Plunged 116 What Caused the Decline 20260521 Sangoma SANG Faces Q1 2026 Headwinds Earnings Come in Below Views Traders Doubt Irans Timeline for Reopening Strait of Hormuz as Geopolitical Risks Persist Disneys The Mandalorian and Grogu Opens to 82 Million Marking a Low Point for Star Wars Franchise Nvidias Record Earnings Fail to Impress as Shares Slip AfterHours Key Economic Data and Corporate Earnings to Watch This Week US Debt Sustainability Concerns Deepen as Bond Market Selloff Intensifies Analysts Suggest Titan Mining Q1 2026 Earnings Strong EPS Surprise Despite Absent Revenue Data ATKR Q1 2026 Earnings Strong EPS Surprise Lifts Shares by 1125 YHGJ Q4 2023 Earnings Positive EPS Lifts Stock Despite Sparse Data SVRA Q1 2026 Earnings EPS Misses Estimates as PreRevenue Biotech Navigates Pipeline Costs Neonode Q1 2026 Earnings EPS Misses Estimates Amid Limited Revenue Disclosure Virtus Diversified Income Convertible Fund ACV Edges Higher Amid Steady Trading HR Block HRB Holds Steady Near 39 as Volume Remains Subdued Palvella Therapeutics PVLA Slips 166 as Shares Test Key Support Levels Reviva Pharmaceuticals Holdings Inc RVPH Holds Steady at 041 as Key Levels Define Trading Range Indian Corporate Balance Sheets Display Maturity as Interest Coverage Ratios Improve FTSE 100 Slips Amid Strait of Hormuz Uncertainty Clouding Iran Deal Prospects UK Spy Chief Warns West Faces Moment of Consequence Geopolitical Tensions May Impact Global Markets Treasury Yields Mixed as Bond Volatility Persists Following Kevin Warshs Fed Chair SwearingIn